The article suggests investors should not base their decisions solely on insider buying but should perform comprehensive research beforehand. Marriott Vacations Worldwide's director purchased 412,449 shares for over $27 million, indicating confidence. Modular Medical's recent insider trades and their plans for a new MODD1 product submission are noteworthy, alongside GeneDx Holdings, which saw significant purchases and positive analyst upgrades, indicating promising growth in the genetic testing market. The emphasis is on informed investing and industry developments.
We would never suggest that investors base their investing decisions solely on insider buying... So, it's just best to do your research first.
Modular Medical just saw director William Wulfsohn buy 2,530 shares for just over $200,957, as it prepares to submit for FDA approval of MODD1.
GeneDx's Keith Meister bought 100,000 shares for $5.6 million, with analysts seeing a path to recovery and strong growth in neonatal testing.
Collection
[
|
...
]